Chinese Regulators Approve Dehaier’s Sleep Diagnostic Device

Dehaier Medical Systems Ltd. has received approval from the Chinese State Food and Drug Administration for its second generation DHR998 sleep diagnostic device.

The DHR998 features a built-in position sensor to identify the flow and SpO₂ change caused by body positioning; an indication light to alert users to an abnormal connect, 24-hour data recording, and a mini-US connection and cable for general use. Its respiratory analysis platform stretches across five testing variables: PPG (plethysmograph), oxygen saturation, heart rate, snoring and body position. By using the Morpheus Ox System, the advanced automatic sleep scoring software generates an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index (AHI), sleep/wake time, and Cheyne-Stokes breathing patterns, the company said.   

“Our new DHR998 sleep diagnostic device is a technological upgrade based on Dehaier’s original sleep diagnostic and monitoring product,” Dehaier CEO/President Ping Chen said. “The new generation Morpheus Ox is a comprehensive platform that manages a cost-effective sleep services operation, including patient electronic medical records, cardiac and sleep diagnostics outcomes and complete workflow management. The web-based automatic scoring and data management quickly gives users valuable clinical information to improve patient treatment.”